Literature DB >> 9375672

Agonist-induced phosphorylation of the kappa-opioid receptor.

S M Appleyard1, T A Patterson, W Jin, C Chavkin.   

Abstract

Antipeptide antibodies against the kappa-opioid receptor were used to test whether acute or chronic exposure to kappa agonists altered the phosphorylation state of the kappa-opioid receptor. Immunoprecipitation of the kappa receptor from guinea pig hippocampal slices preincubated in [32P]orthophosphoric acid revealed a basal phosphorylation of the kappa-opioid receptor. The amount of 32P incorporation into the receptor was increased following a 75-min treatment with the kappa agonist U50,488H. This effect was blocked by the selective kappa receptor antagonist norbinaltorphimine. The time course of this change in the phosphorylation state of the receptor correlated with a desensitization of the electrophysiological response to kappa agonists measured in the dentate gyrus of hippocampal slices. The phosphorylation state of the kappa-opioid receptor was also elevated in brain slices from guinea pigs made tolerant to U50,488H by 5 days of continuous exposure and then maintained in kappa agonist to avoid acute opiate withdrawal. The results of this study show that the kappa-opioid receptor was phosphorylated in an agonist-dependent manner in brain slices taken from untreated and U50,488H-tolerant animals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375672     DOI: 10.1046/j.1471-4159.1997.69062405.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

2.  Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization.

Authors:  O M Kouhen; G Wang; J Solberg; L J Erickson; P Y Law; H H Loh
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 3.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

4.  Identification of novel functionally selective κ-opioid receptor scaffolds.

Authors:  Kate L White; Alex P Scopton; Marie-Laure Rives; Ruslan V Bikbulatov; Prabhakar R Polepally; Peter J Brown; Terrance Kenakin; Jonathan A Javitch; Jordan K Zjawiony; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436

5.  Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels.

Authors:  Caitlin E Scott; Debra A Kendall
Journal:  Methods Enzymol       Date:  2017-07-05       Impact factor: 1.600

6.  Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.

Authors:  W Jin; S Brown; J P Roche; C Hsieh; J P Celver; A Kovoor; C Chavkin; K Mackie
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

7.  Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.

Authors:  Jay P McLaughlin; Lisa C Myers; Paul E Zarek; Marc G Caron; Robert J Lefkowitz; Traci A Czyzyk; John E Pintar; Charles Chavkin
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

8.  Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation.

Authors:  S W Park; Y He; S G Ha; H H Loh; L-N Wei
Journal:  Neuroscience       Date:  2008-01-16       Impact factor: 3.590

9.  G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.

Authors:  Gregory W Terman; Wenzhen Jin; Young-Pyo Cheong; Janet Lowe; Marc G Caron; Robert J Lefkowitz; Charles Chavkin
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

10.  Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.

Authors:  Mei Xu; Michael Petraschka; Jay P McLaughlin; Ruth E Westenbroek; Marc G Caron; Robert J Lefkowitz; Traci A Czyzyk; John E Pintar; Gregory W Terman; Charles Chavkin
Journal:  J Neurosci       Date:  2004-05-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.